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Cell entry of Simian Virus 40 (SV40) involves cav-
eolar/lipid raft-mediated endocytosis, vesicular
transport to the endoplasmic reticulum (ER),
translocation into the cytosol, and import into
the nucleus. We analyzed the effects of ER-
associated processes and factors on infection
and on isolated viruses and found that SV40
makes use of the thiol-disulfide oxidoreduc-
tases, ERp57 and PDI, as well as the retrotrans-
location proteins Derlin-1 and Sel1L. ERp57
isomerizes specific interchain disulfides con-
necting the major capsid protein, VP1, to a
crosslinked network of neighbors, thus uncou-
pling about 12 of 72 VP1 pentamers. Cryo-elec-
tron tomography indicated that loss of inter-
chain disulfides coupled with calcium depletion
induces selective dissociation of the 12 vertex
pentamers, a step likely to mimic uncoating of
the virus in the cytosol. Thus, the virus utilizes
the protein folding machinery for initial uncoat-
ing before exploiting the ER-associated degra-
dation machinery presumably to escape from
the ER lumen into the cytosol.
INTRODUCTION
During entry into host cells, animal viruses typically un-
dergo a process of stepwise destabilization and uncoating
according to a program that is linked in time and space
with the movement of the particle from compartment to
compartment in the cell (Marsh and Helenius, 2006).
In this study, we have analyzed the uncoating and pen-
etration of Simian virus 40 (SV40), a simple, nonenveloped
DNA virus of the polyoma virus family. It uses the ganglio-516 Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc.side GM1 as receptor, and enters host cells by activating
the caveolar/lipid raft pathway of endocytosis (Damm
et al., 2005; Pelkmans et al., 2001; Tsai et al., 2003). After
internalization, the first station is the caveosome, a pH-
neutral, caveolin-containing endocytic organelle distinct
from classical endosomes. From the caveosome, the virus
moves in noncaveolar vesicles along microtubules to the
endoplasmic reticulum (ER) (Kartenbeck et al., 1989; Pelk-
mans et al., 2001). After translocation from the ER into the
cytosol, the virus is thought to enter the nucleus via nu-
clear pore complexes where transcription and replication
take place (Clever et al., 1991; Estes et al., 1971; Nakanishi
et al., 1996).
SV40 and related polyoma viruses are unusual in several
respects. First, their DNA genome is associated with his-
tones in a circular complex containing 20–22 nucleosomes
(Varshavsky et al., 1977). Second, the 50 nm capsids are
composed of homopentamers of themajor capsid protein,
VP1 (43 kDa) associated with one of the minor structural
proteins VP2 or VP3. The virus has icosahedral (T = 7) sym-
metry, andcontains 72pentamers ofwhich 12are five- and
60 six-coordinated (Liddington et al., 1991). The pentam-
ers are connected to each other via C-terminal peptides
extending fromaVP1molecule in onepentamer todocking
sites present in two VP1 molecules of a neighboring pen-
tamer stabilized by calcium ions (Ca2+) (Li et al., 2003).
The pentamers are linked to each other by disulfide bonds
between cysteine 104 (C104) residues (Liddington et al.,
1991).
The aim of our study was to determine why SV40 uses
such an unusual and elaborate entry pathway and to
define possible roles for the ER in the entry process. We
found that isomerization of interpentamer disulfide bonds
in the virus particle plays a central role in the uncoating
process. To initiate disassembly, the virus takes advan-
tage of the protein folding and quality control machinery
present in the ER, before exploiting components of the
ER-associated degradation (ERAD) presumably to escape
from the ER lumen to the cytosol.
Figure 1. ER Processes and ER Proteins
Are Associated with SV40 Infection
CV-1 (A–C) or HeLa (D) cells were infected with
SV40 (one plaque-forming unit (PFU)/cell). The
data represent the average ± SD of three inde-
pendent experiments.
(A) Pharmacological inhibitors were added
30 min prior to addition of virus and present
during infection (100 mMkifunensine, 5 mMcas-
tanospermine, 20 mMMG-132, 5 mMomuralide,
2 mM geldanamycin, 1 mM thapsigargin, and
5 mM DTT).
(B) As in (A). Inhibitors were present either
throughout infection (black), or added at 8 hr
p.i. (white).
(C) 5 mM DTT was added at given times post-
addition of SV40 (solid line). Alternatively, cells
were infected in the presence of 5 mM nocoda-
zole (noc). At 2 hr p.i, noc was washed out, and
5 mMDTTwas added (dashed line). DTT inhibi-
tion was similar with or without noc, a microtu-
bule-dissociating agent that allows virus
uptake into caveosomes but prevents further
transport to the ER (Pelkmans et al., 2001),
and thus confirmed that the DTT sensitive step
occurred after exit from the caveosome.
(D) siRNA silencing was achieved by transfec-
tion of siRNAs (Figure S1). A margin for insig-
nificant pertubations of infection (±20%) was
indicated by dashed lines.RESULTS
ER Processes Associated with SV40 Entry
We first perturbed ER-associated processes in CV-1 cells
and determined 20 hr postinfection (p.i.) whether infection
was affected using a FACS assay based on T-antigen ex-
pression. Inhibitors of proteasomal degradation (MG-132,
omuralide), ER Ca2+ homeostasis (thapsigargin), and di-
sulfide bond formation (DTT) blocked infection (Figure 1A).
When added 8 hr p.i., they failed to affect infection or had
only partial effects, suggesting that inhibition mainly in-
volved early events (Figure 1B). Addition of DTT at various
times after virus addition showed that the step affected
occurred between 4 and 8 hr p.i. with a midpoint at 5.5 hr
p.i. (Figure 1C). This correlated with the arrival of SV40 in
the ER (Kartenbeck et al., 1989). Inhibition of trimming of
N-linked core glycans by kifunensine (ER mannosidase
inhibitor) and castanospermine (glucosidase inhibitor), or
inhibition of GRP94 and other members of the heat shock
protein 90 chaperones had little effect (Figure 1A).
Next, siRNA-mediated knockdown of ER proteins was
performed in HeLa cells.We confirmed by immunoblotting
that the level of target protein was reduced (Figures S1A–
S1F in the Supplemental Data available with this article
online). While no effect was observed on VSV infectivity
(a virus that does not enter via the ER route, Figure S1H),
depletion of two ER thiol-disulfide oxidoreductases, pro-
tein disulfide isomerase (PDI) and ERp57, significantly
reduced SV40 infection (Figure 1D). In contrast, depletion
of the oxidoreductase TMX3 or ERp29 (an ER protein with
thioredoxin-like fold but lacking the catalytic site), and thetwo glycoprotein chaperones, calnexin (CNX) and calreti-
culin (CRT), had no effect (Figure 1D). Silencing of ERp72,
another abundant ER thiol-disulfide oxidoreductase, gave
divergent results for two independent siRNAs that both
reduced ERp72 levels; one enhanced infection, and the
other had no effect (Figure 1D).
Significant inhibition of infectionwas also observed after
silencing of Derlin-1 and Sel1L (sel-1 suppressor of lin-like
protein, Figure 1D), two transmembrane proteins involved
in the export of misfolded proteins from the ER to the
cytosol for proteasomal degradation (Mueller et al., 2006;
Ye et al., 2004).
The results implied that ER factors involved in disulfide
bond oxidation, reduction, and isomerization were critical
for productive entry. In addition, calcium homeostasis and
ER-associated degradation (ERAD) seemed to play a role.
Free Sulfhydryl Groups and Disulfide Bonds
in Intact Virions
To pursue the oxidoreductases, we first analyzed whether
disulfides and free cysteines in the virus were important
for infectivity. We found that treatment of isolated virus
with 5 mM DTT resulted in full reduction of all disulfide
bonds in the particle (see below) but did not affect infectiv-
ity (Figure 2A) and neither did treatment with the thiol oxi-
dant, diamide. However, alkylation using 4-acetamido-40-
maleimidylstilbene-2,20-disulfonicacid (AMS),or iodoacetic
acid (IAA), reduced infectivity by 70%–80%, suggesting
that one or more free sulfhydryl groups were critical (Fig-
ure 2A). Alkylation or reduction of viruses did not affect
internalization or transport to the ER, as shown by theCell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc. 517
Figure 2. Free Sulfhydryls in SV40 Are Critical during Entry
CV-1 cells were infectedwith SV40 (1 PFU/cell [A]; 10 PFU/cell [B]). The
data represent the average ± SD of three independent experiments.518 Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc.colocalization of virus with caveolin-1 2 hr p.i. or with the
ER marker PDI 8 hr p.i. (Figure 2B).
VP1 is the only protein in SV40 that has cysteines. The
X-ray structure shows that four of the seven cysteines
(C87, C207, C254, and C267) are reduced and hidden
within the folded protein or in the interphase between the
subunits (Figures S2A and S2B). C49 is also reduced but
partially exposed on the pentamer surface (Figure S2B,
arrowhead). C104 residues form interchain disulfidebonds
with eachother linkingVP1subunits in adjacent pentamers
(Liddington et al., 1991; Stehle et al., 1996). Around the 12
pentamers located at the vertex of the icosahedral capsid,
the situation is special because here the C104 from a VP1
in a five-coordinated pentamer is in close proximity to two
C104 residues from VP1 in two adjacent six-coordinated
pentamers (Figure S2C). The three cysteines form one
disulfidewhile one C104 is reduced. The seventh cysteine,
C9, is part of a 13-residue, N-terminal peptide that is not
visible in the X-ray structure but thought to be hidden
below the pentamers (Liddington et al., 1991). The inac-
cessibility of C9 to mercury labeling suggests that it may
be disulfide bonded (Liddington et al., 1991).
To determine how many cysteines in VP1 of intact vi-
ruses were alkylated, we used a gel-shift assay based on
the 5 kDa increase in the molecular weight of a protein for
each cysteine alkylated by polyethylene glycol maleimide
(malPEG). The observed shift indicated that only one free
cysteine was accessible for alkylation, and this only in a
fraction of VP1 molecules (Figure 3A, lane 2). To identify
the accessible cysteine(s), we treated the virus with dif-
ferent alkylating agents adding distinguishable masses
as outlined in Figure 3B. Subsequent mass spectrometry
showed that some C104 and C49 were alkylated indicat-
ing that they were reduced and accessible in the intact
virus particle (Figures 3B–3D and S3B and S3C). After
DTT treatment of the virus, additional cysteines became
accessible for alkylation. In addition to C104, C9 was now
also alkylated indicating that in the intact virus it must be
oxidized (Figures 3B–3D and S3B and S3C). Since C104
was exclusively paired with C104 and all other cysteines
were reduced in the intact virus, we concluded that C9
was present in C9-C9 disulfides.
When the virus was analyzed by nonreducing SDS-
PAGE after treatment with iodoacetamide (IAM) before
and during exposure to SDS to alkylate free sulfhydryl
groups in VP1, the majority of VP1 hardly entered the gel
(Figure 3E, lane 3, arrow). We concluded that in intact
viruses, theVP1proteinswere extensively crosslinkedwith
each other through a network of C104-C104 and C9-C9
disulfide bonds. Thiswas confirmedusing sucrose velocity
(A)SV40was thiol-disulfidemodifiedby reduction (5mMDTT), oxidation
(5mMdiamide), or alkylation (5mMAMSor IAA)prior toaddition tocells.
(B) Cells were infectedwith AF488 labeled SV40 in the absence or pres-
ence of 5 mM DTT. Alternatively, alkylated AF488 labeled SV40 (5 mM
AMS) was added. Cells were fixed at 2 or 8 hr p.i., and immunostained
for caveolin-1 or PDI, respectively. After confocal image aquisition, the
amount of colocalization of SV40 (green) with cellular markers (red) was
quantified and normalized to SV40 in the absence of DTT.
gradient centrifugation of alkylated and SDS-solubilized
virus. The SDS-denatured viruses sedimented homoge-
neously as 125S particles (Figure 3F). Only aminor fraction
of VP1 dissociated from these denatured particles, and
was found on top of the gradient. To form such an exten-
sive disulfide network, we surmised the C104-C104 disul-
fides connected adjacent pentamers as shown by the
X-ray structure, whereas the C9-C9 disulfides were likely
to occur both between pentamers and within pentamers.
The presence of C9-C9 and C104-C104 disulfides was
confirmed by analyzing SV40 mutants in which cysteines
C9 and C104 had been replaced with alanine (Ishii
et al., 1994). Analysis by nonreducing SDS-PAGE showed
that C9A or C104A mutants contained VP1 dimers and
monomers,whileC49Amutants exhibited crosslinkedVP1
oligomers exactly as the wild-type (Figure 3G, lanes 1–4).
The double mutant C9A/C104A was devoid of disulfide
crosslinked species and contained only monomers (Fig-
ure 3G, lane 5). This confirmed our conclusion that C9-C9
and C104-C104 disulfide bonds provide the crosslinks
between VP1 molecules in the particle.
Loss of Interchain Disulfide Bonds
during SV40 Entry
While the network of interchain disulfidebonds contributes
to the stability of extracellular virus particles, elimination of
some of the bonds is probably necessary for uncoating
and release of the genome during virus entry.
To determine whether interchain disulfide bonds were
actually lost during infection, alkylated and nonalkylated
virus particles were allowed to enter cells for different time
periods up to 10 hr. The fraction of VP1 no longer cross-
linked to the network of disulfides was determined by
alkylating the cell lysates, treating them with SDS, and
subjecting them to nonreducing SDS-PAGE. Immunoblot-
ting showed that while the majority of interchain disulfide
bonds in incoming viruses remained intact, a fraction of
VP1 molecules was released from the disulfide bonded
network showing up as monomers in the SDS-gel. The
amount of VP1 released by SDS remained at values below
2% until 6 hr p.i., when it increased to about 20% (Fig-
ure 4A). The time course of disconnection coincided with
virus arrival in the ER.
Interestingly, the alkylated viruses did not show release
of monomeric VP1 during infection, suggesting that free
sulfhydryl groups were needed to release VP1 molecules
from the disulfide crosslinked network, a requirement con-
sistent with amechanism based on disulfide isomerization
rather than disulfide reduction. Since the alkylated virus
was non infectious, the result also implied that the loss
of interchain disulfides was an essential part of the pro-
ductive entry pathway.
Depletion of ERp57 by siRNA blocked the generation of
decrosslinked VP1 in HeLa cells (Figure 4B). When PDI
was similarly depleted, no effect was observed. This indi-
cated that it was ERp57 that catalyzed the loss of inter-
chain disulfides. That this occurred by disulfide isomeriza-
tion rather than reduction was shown by the slightly fasterCmigration of the released VP1 compared to the DTT
reduced form of the same protein (Figure 4A, lanes 6–9).
Such differences in mobility indicate presence of intra-
chain disulfides. Since the X-ray structure of VP1 shows
no intrachain disulfides in the intact virus, one or more in-
terchain disulfide bond(s) must have been converted by
ERp57 to intrachain disulfides by isomerization.
Analysis of SV40 cysteine mutants provided additional
insight into the role of disulfide bonds and ERp57. Al-
though formation of these mutant viruses (particularly of
the C104A mutant) was slower and less efficient than
wild-type SV40, we could confirm that they all were infec-
tious. As expected, siRNA-mediated depletion of ERp57
reduced infection of the C49A mutant as much as of
wild-type SV40 (Figure 4C). However, ERp57 depletion
did not affect infectivity of the C9A/C104A mutant, a virus
lacking disulfide crosslinks between pentamers (Fig-
ure 4C). This confirmed that the role of ERp57 is, indeed,
linked to the elimination of C9-C9 and/or C104-C104 inter-
chain disulfide bonds. If such disulfides are lacking as in
the C9A/C104A double mutant, ERp57 is dispensable. It
is noteworthy in this context, that the C9A/C104A mu-
tant—like the C49A mutant and the wild-type virus—was
sensitive to DTT (Figure 4D). This indicated that the inhib-
itory effect of DTT was not due to reduction of viral disul-
fides, but rather to an effect on cellular factors.
ERp57 and PDI Modify SV40 Disulfides In Vitro
Incubation of isolated virus in cytosolic extracts or in a buf-
fer mimicking the reducing and Ca2+-free environment of
the cytosol failed to induce loss of interchain disulfides in
SV40 (Figure 5A, lanes 4 and 5, and Figure 5B). The same
was foundwhen the viruswas incubated in abuffermimick-
ing the oxidizing conditions of the ER (Figure 5A, lane 5).
However, when either isolated PDI or ERp57 were
added to the redox buffer, significant loss of interchain
disulfides was observed using the SDS-PAGE assay (Fig-
ures 5D and 5E, lanes 3–6). Again, about 20% of the VP1
proteins were found to be uncoupled from the capsids us-
ing either of the oxidoreductases. When the two enzymes
were inactivated by alkylation, no release of VP1 occurred
indicating a direct role for the thiol-disulfide oxidoreduc-
tase function (Figures 5D and 5E, lane 7). The full effect
was reached with one oxidoreductase molecule per ten
viruses indicating a catalytic effect. Incubation with both
oxidoreductases together did not increase the amount of
monomeric VP1 (Figure 5F, lane 4).
To investigate whether ERp57 and PDI served as reduc-
tases or isomerases in vitro, alkylated SV40 was used as a
substrate. PDI was found to release a similar amount of
reducedVP1as fromcontrol virus (Figure5E, lane8). ERp57
failed to release any VP1 (Figure 5D, lane 8). Hence, ERp57
seemed toactasan isomerase,PDIasa reductase.Wealso
investigated whether Ca2+ chelation would increase the ef-
ficiency of VP1 release. Only PDI showed such an increase
(Figures 5D and 5E, lane 9), suggesting that PDI acts most
efficiently on disulfides when the SV40 particle has under-
gone a structural change induced by the loss of Ca2+ ions,ell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc. 519
Figure 3. Characterization of SV40 Cysteines in Intact Virions
(A) Intact SV40 particles were alkylated by malPEG, followed by DTT reduction and alkylation of all remaining cysteines by IAA in the presence of SDS
(lane 2). Alternatively, SV40 was reduced in the presence of SDS and alkylated with IAA (lane 1) or with malPEG/IAAmixtures (as indicated). The latter
identified band shifts conferred by single or multiple (up to four) malPEG modifications (lanes 3 and 4) Numbers indicate the order of addition of the
reagents.
(B) Outline for the identification of the individual SV40 cysteines present as free sulfhydryls or disulfide bonded by mass spectrometry. Strategy 1
labeled reduced and exposed cysteines differently than all other cysteines by alkylation with IAM of intact SV40. All further cysteines were alkylated520 Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc.
e.g., through the externalization of the C-terminal arm of
VP1, which is normally held in place by the cation.
The monomeric VP1 generated in vitro after ERp57 and
ERp57/PDI incubation migrated identically to VP1 re-
leased during infection in vivo (Figure 5F, compare lanes
1, 3, and 4). In contrast, the band generated by PDI alone
migrated like the completely reduced species (Figure 5F,
lanes 2 and 5). This was consistent with a disulfide isom-
erization from interchain to intrachain disulfides in VP1
by ERp57, but not by PDI.
The results showed that ERp57 eliminates interpenta-
meric disulfide bonds in SV40. As during cell entry, ERp57
catalyzes in vitro the disconnection of about 20% of pen-
tamers by disulfide isomerization. In contrast, PDI induces
reduction of disulfides in vitro, a reaction that does not
occur during virus entry.
Release of Five-Coordinated Pentamers
Judging by the mobility of VP1 in SDS gels, the stabilizing
network of disulfide crosslinks was eliminated by treat-
ment with DTT (Figure 3A, lane 2). This did not cause dis-
sociation of the particle. Velocity centrifugation of reduced
virus showed only a shift in the sedimentation coefficient
from 250S for control virus to 245S (Figure 6A). A similar
shift was seen when the virus was treated with the
Ca2+-chelating agent EGTA to remove the VP1-bound
Ca2+ ions, and thus weakened the interpentamer connec-
tions provided by the invading C-terminal arms. Negative
stain electron microscopy indicated that when applied
alone,bothof these treatments inducedpenetrationof stain
into the capsids, consistent with loosening pentamer con-
tacts, but the particles remained intact (Figure 6B, b and c).
However as previously reported (Hartmann and Scott,
1981), a major structural change occurred when DTT
and EGTA were added together. EM showed release of
doughnut-shaped particles with a diameter of 12 nm
corresponding most likely to VP1 pentamers (Figure 6B, d
and e). However, amorphous capsid structures were still
present with visible capsomers (Figure 6B, d).
Sucrose velocity gradient sedimentation analysis
showed that combined DTT-reduction and Ca2+ chelation
resulted in two peaks of VP1 corresponding to pentamers
at the top of the gradient and modified capsids that sedi-Cmented at 230S (Figure 6A). The 230S particles contained
the viral DNA but only about half of the VP1 and VP2/VP3
proteins (Figures 6C and 6D). Partial uncoating of the virus
could thus be induced in vitro by combined reduction of
interchain disulfide bonds and extraction of the VP1 asso-
ciated Ca2+ ions.
When the partially uncoated viruses were viewed by
cryo-electron microscopy with tomographic reconstruc-
tion, the particles had lost the capsomers located at the
vertices but retained all six-coordinated capsomers (Fig-
ures 6F and S4). This suggested that the 12 five-coordi-
natedpentamerswere less tightly associated than the rest,
and dissociated selectively when the interchain disulfides
and the associations provided by C-terminal peptides
were lost. Interestingly, whenSV40 capsids devoid of DNA
(‘‘empty particles’’) were subjected to the same disassem-
bly conditions, no remnant capsids were observed. The
entire capsid dissociated into slowly sedimenting pentam-
ers (Figure 6E). It is thus possible that the viralminichromo-
some, located in the central cavity, interacts with pentam-
ers and increases the stability of the particle.
While no obvious structural alterations of SV40 particles
incubated in vitro with ERp57 and/or PDI could be ob-
served by EMafter negative staining, sucrose velocity gra-
dient centrifugation showed the release of 9% of pentam-
ers after Ca2+ chelation (Figure 6G). This indicated that
both reduction and isomerization of disulfides in vitro can
lead to pentamer release. For pentamer dissociation how-
ever, the loss of disulfide bonds is not sufficient; loss of
Ca2+ ions is also required.
Pertubation of ERAD Affects Infection
Thenotion thatSV40entry involves theERADpathwaywas
suggested by the sensitivity of infection to proteasome in-
hibitors and to the silencing of Derlin-1 and Sel1L, two pro-
teins involved in retrotranslocation (Figures 1A and 1D)
(Mueller et al., 2006; Ye et al., 2004). The dependence on
PDI for infection (Figure 1D) also indirectly supported
such a connection because Forster et al. (2006) reported
that PDI depletion causes ER retention of misfolded pro-
tein substrates. In contrast, depletion of ERp72, another
abundant PDI-like protein in the ER, increases retrotrans-
location of misfolded proteins (Forster et al., 2006).by MMTS, after DTT reduction and SDS-denaturation. Strategy 2 labeled the reduced and exposed as well as the disulfide bonded cysteines differ-
ently than the reduced and hidden species (gray) by DTT reduction followed by IAM alkylation. IAM was quenched with DTT, and hidden cysteines
were alkylated byMMTS in the presence of SDS. Samples were submitted to SDS-PAGE and Coomassie staining. VP1 was excised and subjected to
an in-gel trypsin digest; peptides were eluted and analyzed by mass spectrometry. The mass difference for IAM and MMTS was used to distinguish
individual cysteines.
(C) Summary of the thiol-modifications of VP1 cystein residues detected by mass spectrometry (see also Figure S3 and Tables S1 and S2).
(D) Ribbon diagram of a single VP1molecule as present in a pentamer. Highlighted in red are the cysteine residues. Dashed lines indicate reduced and
exposed cysteines; solid lines indicate disulfide bonded cysteines.
(E) Nonreducing SDS-PAGE and Coomassie staining of purified SV40 after treatment with SDS, DTT (lane 1), or after subsequent treatment with DTT,
IAM, and SDS (lane 2), with IAM and SDS (lane 3), or with IAM, DTT, and SDS (lane 4). Numbers indicate the order of addition of reagents. All disulfides
could be reduced prior to addition of SDS (lane 2). Arrowhead indicates minor amounts of dimers (lane 3).
(F) Sedimentation analysis of IAM-alkylated and SDS-denatured (as in [E], lane 3) as compared to untreated SV40 on a linear 5%–20% sucrose
gradient.
(G) Wild-type and mutant SV40, where single or double cysteines had been exchanged for alanine, were produced by pNO-SV40-VP1 transfection
(lanes 1–5). As control, wild-type SV40 grown by infection was used (lane 6). Preparations were alkylated (IAM), subjected to nonreducing SDS-PAGE,
and immunoblotted against VP1. Arrowhead indicates monomers in the C104A mutant (lane 4).ell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc. 521
Figure 4. ERp57-Mediated Isomerization of SV40 Disulfides Decrosslinks VP1 Molecules
(A) CV-1 cells were infected with either untreated or AMS-alkylated SV40 (10 PFU/cell) for indicated times p.i. (lanes 4–9). As controls, SV40 was
bound to cells at 4C (lane 3) or infection occurred in the presence of 5 mM nocodazole (lane 2) to prevent internalization or transport from caveo-
somes, respectively. Cell lysates were prepared after alkylation with MMTS or NEM (data not shown). Lysates were analyzed by nonreducing SDS-
PAGE and were immunoblotted against VP1. The VP1 antiserum showed much higher affinity against disulfide crosslinked molecules (especially
dimers) than monomeric VP1. Hence, relative signal intensities of monomeric VP1 (boxed) were always compared to the fully reduced input (lane 9).
The mean values of three independent experiments ± SD are shown.
(B) PDI and ERp57 were silenced by siRNA transfection in HeLa cells prior to infection with SV40 (50 PFU/cell). The proteins of infected cells were
alkylatedwith 5mMMMTS (10 hr p.i.). Cell lysateswere analyzed by nonreducing SDS-PAGEand immunoblotted against VP1.Quantification as in (A).
(C) HeLa cells silenced for ERp57 were infected with mutant and wild-type SV40 (1 PFU/cell).
(D) CV-1 cells were infected with mutant and wild-type SV40 (1 PFU/cell) in the presence or absence of DTT.
The data represent the average ± SD of three independent experiments.522 Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc.
Figure 5. ERp57 Isomerizes SV40 Disulfide Bonds In Vitro
(A) SV40 was incubated for 1 hr (37C) in glutathione redox buffer in the presence or absence of 5 mM EGTA. The molecular ratios of reduced versus
oxidized glutathione (GSH:GSSG) mimicked reducing cytosolic (100:1, lanes 4 and 5) or oxidizing ER conditions (1:1, lane 6). After 5 mM IAM
alkylation, nonreducing SDS-PAGE, and immunoblotting against VP1, the amount of monomeric VP1 was determined as compared to the DTT
reduced input. Mean values of relative signal intensities ± SD are shown.
(B) SV40 was incubated for 1 hr (37C) in cytosolic extracts from HeLa cells. Analysis as in (A).
(C) SDS-PAGE and Coomassie staining of purified ERp57 or PDI.
(D) 50 nM SV40 were incubated for 1 hr (37C) in ER redox buffer in the presence or absence of 5 mMEGTA with purified ERp57 in the stoichiometries
indicated. As controls, alkylated SV40 or alkylated ERp57 were used. Analysis as in (A).
(E) As in (D) using PDI instead of ERp57.
(F) Comparison of monomeric VP1 released during infection or in vitro. SV40was treated for 1 hr (37C) with 5 mMDTT (lane 2), ERp57 (as in [D], lane 3),
PDI (as in [F], lane 5), or both thiol-disulfide oxidoreductases in equal amounts (lane 4) in vitro. Alternatively, CV-1 cells were infected for 10 hr p.i.
(lane 1). Subsequently, in vitro samples or cell lysates were alkylated (5 mM MMTS), submitted to nonreducing SDS-PAGE, and immunoblotted
against VP1.Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc. 523
Figure 6. In Vitro Disassembly of SV40
Representative examples of three independent experiments are shown ([A–E] and [G]).
(A) Sucrose sedimentation analysis on a linear 5%–20% sucrose gradient of untreated, 5 mM DTT, 5 mM EGTA, or DTT/EGTA (5 mM/5 mM)-treated
SV40. Fractions were immunoblotted against VP1.
(B) SV40 (a) was incubated with DTT (b), EGTA (c), or DTT/EGTA (d and e) as in (A), and analyzed by negative EM. Scale bars represent 100 nM.
(C) Sedimentation as in (A) after DTT/EGTA incubation of SV40. To determine the viral DNA, sampleswere phenol/chloroform extracted, and DNAwas
EtOH precipitated and quantified.
(D) As in (A). Fractions immunoblotted against VP1 and VP2/VP3.
(E) As in (A). Instead of infectious SV40, so-called empty particles lacking the minichromosome were used.
(F) Surface rendering of the three-dimensional structure of SV40 from cryo-electron tomography after icosahedral symmetrization without (blue) or
with (yellow) preincubation with DTT/EGTA. Left structure pair shows the typical orientation of the capsomers, the right structure pair is rotated
horizontally to allow the view onto a vertex, revealing the missing vertex in the DTT/EGTA-treated SV40. Control virus represents average of multiple524 Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc.
To pursue the issue further, we tested whether the cys-
teinemutants C49A and C9A/C104Awere also dependent
on these factors. Infectivity of mutant and wild-type SV40
was similarly sensitive to proteasome inhibitors, and toPDI
and Derlin-1 depletion (Figures 7A and 7B). The sensitivity
of the C9A/C104A mutant showed that the step affected
by these perturbations was independent of the ERp57-
mediated disulfide isomerization step.
To confirm that retrotranslocation was affected by these
perturbations, we measured the level of polyubiquitinated
proteins in cells using SDS-PAGE combined with immu-
noblotting for polyubiquitin tagged proteins (Figure 7C).
We found as expected that incubation with the protea-
some inhibitor MG-132 resulted in accumulation of poly-
ubiquitinated proteins. However, when Derlin-1 or Sel1L
were depleted by siRNAs andMG-132 added, fewer poly-
ubiquitinated proteins accumulated compared to control
cells, suggesting that misfolded proteins failed to exit the
ER and thus, failed to be ubiquitinated (Figure 7D). Deple-
tion of ERp57 by siRNAs had no effect while the depletion
of PDI by siRNAs resulted in a clear reduction in the level
of polyubiquitinated protein in the presence of MG-132
(Figure 7D). In ERp72 depleted cells, the situation was
less clear. An increase was seen for the same siRNA that
also dramatically enhanced SV40 infectivity (Figure 7D).
We concluded that when PDI levels were reduced, and
retrotranslocation was impaired, SV40 infectivity was sup-
pressed, while ERp72 depletion, which had the opposite
effect on retrotranslocation of proteins, seemed to enhance
SV40 infectivity. Together with the effects of Derlin-1 and
Sel1L silencing, these results were consistent with a role
for ER retrotranslocation in SV40 entry.
DISCUSSION
Our results indicated that SV40 has chosen the ER route of
entry so that it can take advantage of the protein folding
and quality control machinery in the ER for initial uncoating
and membrane translocation. Through an ERp57-cata-
lyzed disulfide isomerization reaction in the ER lumen, a
sub-population of pentamers (most likely the 12 vertex
pentamers) are disconnected from an extensive network
of disulfide crosslinked VP1 molecules in the capsid, the
first step in the uncoating of SV40. The dependence on
Derlin-1, Sel1L, and PDI suggested that the modified virus
makes use of the ERAD pathway presumably for transport
into the cytosol. We hypothesize that the vertex pentam-
ers are lost when the virus reaches the low Ca2+ in the
cytosol. The overall strategy used by SV40 is thus similar
to that previously described for cholera toxin but more
elaborate due to the structural complexity of the particle
(Tsai et al., 2001).We found that the SV40 capsid is extensively cross-
linked by interpentameric and possibly also intrapenta-
meric C104-C104 and C9-C9 disulfide bonds between
VP1 molecules. The C9-C9 bonds are not visible in the
X-ray structure because the terminal residues of the N-
terminus are disordered (Liddington et al., 1991). Through
these bonds, virtually all VP1 molecules in the particle are
covalently connected with each other.
The main function of the disulfide bond network is most
likely to stabilize the virus during extracellular passage. Al-
though the virus remains intact after reduction of all disul-
fides, it is less stable particularly in a low calcium environ-
ment. Mutations in C9, C104, or both have been shown
to result in formation of unstable particles that possess
reduced infectivity (Gharakhanian et al., 2001).
Of the VP1 cysteines, C9, C104, and C257 are con-
served amongpolyoma viruses. Interestingly, an extended
disulfide bonded network is not present inmouse polyoma
virus. The X-ray structure shows the presence of C19-
C114 intrachain disulfides. In SV40, these correspond to
C9-C104 disulfides. Although polyoma virus also enters
the ER, recent studies suggest that the uncoating mecha-
nismsmay be different (Lilley et al., 2006; Magnuson et al.,
2005).
A covalently crosslinked capsid shell obviously necessi-
tates special measures during entry. To allow opening of
the capsid and release of the viral chromosome, at least
some of the crosslinks must be eliminated. We found that
about 20% of the VP1 molecules were in fact uncoupled
from an otherwise intact network of disulfide-bonded
VP1s. Since the VP1 s in the mature particle contain no in-
trachain disulfide bonds, such bonds in the disconnected
VP1s likely resulted from an isomerization reaction in
which an interchain disulfide was isomerized to an intra-
chain disulfide. When the acceptor cysteines were alky-
lated, no isomerization was possible, no VP1 molecules
were released, and the virus was noninfectious. When
SV40 was incubated in a cytosolic extract or in glutathione
redox buffers mimicking conditions in the ER or cytosol,
there was no reduction or isomerization of disulfides, con-
sistent with the need for a thiol-disulfide oxidoreductase in
the isomerization process.
The evidence that ERp57 was the thiol-disulfide oxido-
reductase required was four-fold. First, siRNA silencing of
this abundant, soluble ER enzyme resulted in a 5-fold
reduction of SV40 infection. Second, with ERp57 silenced,
VP1 disconnection from the disulfide crosslinked network
did not occur. Third, incubation of SV40 in vitro with iso-
lated ERp57 reproduced in every detail the observations
made in vivo. Finally, infection by the C9A/C104A mutant
that lacks disulfide bonds was not sensitive to ERp57
silencing.viruses; while due to the overall heterogeneity in virus diameter in the DTT/EGTA-treated population, the structure shown is from one capsid to allow
a clearer view for the hexameric capsomers. The missing vertex density was, despite the heterogeneity in this preparation, the striking feature of the
structure averaged from all reconstructed DTT/EGTA-treated capsids.
(G) Sedimentation of SV40 after incubation with ERp57 or PDI, and EGTA addition (as in Figures 5D and 5E, lane 9) on a linear 5%–20% sucrose
gradient. Fractions were immunoblotted against VP1. EGTA addition was essential for pentamer release.Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc. 525
Figure 7. Interference with ER to Cytosole Retrotranslocation Coincides with Pertubation of SV40 Infection
(A) CV-1 cells were infected with SV40 (wild-type and cysteine mutants) in the presence or absence of the proteasome inhibitor MG-132 (20 mM). The
data represent the average ± SD of three independent experiments.
(B) HeLa cells that were silenced with siRNAs directed against Derlin-1, PDI, or Luciferase were infected with SV40 (wild-type and cysteine mutants).
The data represent the average ± SD of three independent experiments.
(C) HeLa cells were treated with MG-132 for 16 hr. Cell lysates were subjected to SDS-PAGE and immunoblotted against ubiquitin. Shown are the
polyubiquitinated proteins (poly-Ub). Poly-Ub levels as compared to MG-132-treated cells were depicted as mean ± SD.
(D) Poly-Ub levels under siRNA-silencing conditions: HeLa cells were silenced for Derlin-1, Sel1L, PDI, ERp57, or ERp72, and all cells were treated
for16 hr with MG-132 prior to cell lysis. Poly-UB levels as compared to control cells (Luciferase) were depicted as mean ± SD.Our results suggested that ERp57 reduces a C9-C9
disulfide and replaces it with the C9-C104 intrachain disul-
fide by using the free C104 in the threesome of cysteines
at the vertex as acceptor. The corresponding C19-C114
disulfide of mouse polyomavirus indicated the feasibility526 Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc.of this connection (Stehle et al., 1996). It is noteworthy,
that only at the vertex, a cluster of three closely spaced
C104 residues involving one VP1 of a five-coordinated
pentamer and two VP1s in neighboring six-coordinated
pentamers exists (Stehle et al., 1996; Figure S2). The
weak electron density in this region could be explained by
flexibility and/or by randomness as to which of the cyste-
ines participate in the C104-C104 disulfide bond (Stehle
et al., 1996). With two of the C104 cysteines disulfide
bonded, one must remain reduced. Our results indicated
that this free sulfhydryl was essential in the initial uncoat-
ing process; when it was alkylated the virus reached the
ER but failed to infect. The second cysteine residue
accessible for alkylation, C49, is located too far from the
disulfides to serve as an acceptor for isomerization, and
the properties of the C49A mutant virus did not differ from
the wild-type.
As a consequence of the loss of the C9-C9 disulfide, the
covalent connections between the vertex pentamers and
the hexavalent neighbors are lost. Although 20% of the
VP1 molecules no longer participate in the disulfide-
bonded network, all pentamers remain associatedwith the
virus particle as long as the Ca2+ ions are in place. Our
in vitro experiments using cryo-electron tomography and
mass spectrometry suggested that the pentamers discon-
nected from the crosslinked network constitute the 12
vertex pentamers. At least in vitro, we found that the re-
lease of these pentamers from a reduced particle required
extraction of the Ca2+ ions known to stabilize the interac-
tion between VP1 and the C-terminal arm of a neighbor-
ing VP1. Thus, to release the vertex pentamers, both the
covalent disulfide connections had to be broken and the
C-terminal arms had to dissociate from the neighboring
pentamers.
Although clearly favored by our observations, a role for
ERp57 inSV40 uncoating raised somequestions. Howcan
this enzyme reach cysteines and disulfide bonds located
on the inner surface of the capsid wall? The dimensions
of ERp57 can be deduced from the crystal structure of
the b-b0 domain and analytical ultracentrifugation studies;
the thioredoxin-like domains have a diameter of about
3.5 nm (Frickel et al., 2004; Kozlov et al., 2006). The X-ray
structure of the virus shows that the capsid wall has open-
ings of about 3-5 nm in size (Liddington et al., 1991), which
may be big enough if one considers the dynamics of viral
capsids, i.e., so-called ‘‘breathing’’ (Lewis et al., 1998),
and if one assumes a flexible structure for the oxidoreduc-
tase (Tian et al., 2006).
Another question concerns the association of ERp57
with calnexin (CNX) and calreticulin (CRT), and its function
as a thiol-disulfide oxidoreductase for glycoproteins. We
did not observe any effect on infectivity by inhibitors that
block glycoprotein trimming and entry into the CNX/CRT
cycle. siRNA silencing of CNX and CRT failed to affect
virus infection. It is therefore likely that ERp57 interacts
with SV40 independently of CNX and CRT.
While essential for productive entry of the wild-type
virus, we found that ERp57 was dispensable for the C9A/
C104A mutant, a virus devoid of disulfide bonds. That this
mutant virus was still sensitive to DTT, to proteasome
inhibitors, and to the depletion of Derlin-1, Sel1L, and PDI
indicated that there are ER-associated steps during entry
beyondERp57-induced rearrangement of disulfidebonds.That these events included translocation of the virus from
the ER lumen to the cytosol was suggested by the identity
of the factors and inhibitors identified. Derlin-1 is a mem-
brane protein involved in the translocation of ERAD sub-
strates from the ER to the cytosol for degradation by pro-
teasomes (Ye et al., 2004). Sel1L is predicted to be a type I
transmembrane protein and thought to function in sub-
strate recognition for ERAD (Mueller et al., 2006). PDI
silencing has been shown to inhibit polyubiquitination of
proteins and retrotranslocation of misfolded proteins (For-
ster et al., 2006; Tsai et al., 2002), and proteasome inhib-
itors can impair retrograde transport of ERAD substrates
(Hirsch and Ploegh, 2000). Finally depletion of ERp72,
another abundant thiol-disulfide oxidoreductase, by an
siRNA that enhanced retrotranslocation of ERAD sub-
strates (Figure 7B)(Forster et al., 2006), also enhanced
SV40 infection.
These observations indicate that SV40 exploits a ma-
chinery in the ER normally reserved for identification of
misfolded proteins and for retrotranslocation of these
proteins through the ER membrane. The ER is the only or-
ganelle in the cell that possesses a retrotranslocation sys-
tem for macromolecules, a system known to be exploited
by certain bacterial toxins and possibly other viruses
(Lilley et al., 2006; Tsai et al., 2002). How this interaction
works for SV40 at the molecular level poses an interest-
ing problem given the large size of the virus particles.
Future work will have to obtain direct evidence on how
the translocation of the virus from the ER to the cytosol
is achieved.
The overall process is likely to involve additional
changes in the virus such as exposure of VP2/VP3 either
in the ER lumen or after translocation (Daniels et al.,
2006; Norkin et al., 2002), and the exposure of nuclear
localization signals required for import into the nucleus
(Clever et al., 1991; Nakanishi et al., 1996). Although we
have shown here that uncoating starts in the ER by the
isomerization of disulfide bonds, we find it likely that pen-
tamers dissociate from the particle in the cytosol when the
virus encounters a milieu with a low Ca2+ concentration.
The inhibitory effect of thapsigargin may be explained by
the elevation in Ca2+ in the cytosol (Scharff et al., 1988).
The stepwise uncoating program of SV40, which we par-
tially unraveled in this study, clearly provides many inter-
esting questions for future investigation.
EXPERIMENTAL PROCEDURES
Cells, Viruses, Antibodies, and Materials
CV-1 and HeLa cells were from ATCC. SV40 was grown in CV-1 cells,
purified, and flourescently labeled as described (Pelkmans et al.,
2001). Mutant SV40 and recombinant VSV expressing GFP were
prepared as described (Ishii et al., 1994; Pelkmans and Zerial,
2005). Antibodies were from StressGene (PDI, SPA890; ERp72,
SPS720), Santa Cruz Biotechnology (caveolin-1, Cav1N2), Alexis Bio-
chemicals (Sel1L, MSel1), or Sigma (beta-actin, AC-15; ubiquitin,
U5379). Antibodies against T-antigen (T-ag), VP1, ERp29, TMX3,
and ERp57 have been described (Frickel et al., 2004; Haugstetter
et al., 2005; Pelkmans et al., 2001, 2002; Rainey-Barger et al.,Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc. 527
2007). VP2/3 antiserum was raised in rabbits immunized with the
synthetic C-terminal VP2/3 peptide (CSASAKARHKRRNRSSRS).
Secondary antibodies and AMS were from Molecular Probes. Methyl
methanethiosulfonate (MMTS) and N-ethylmaleimide (NEM) from
Pierce, malPEG from Eprova, MG-132 and thapsigargin from Calbio-
chem, omuralide from Cayman Chemicals, kifunensine from Toronto
Research Chemicals, and geldanamycin from AG Scientific. All other
reagents were from Sigma.
Infection Studies
Cells were infectedwith SV40. At 20 hr p.i., cells were trypsinized, fixed
in 4% formaldehyde, permeabilized with 0.05% saponin, and incu-
bated in FACS buffer (20 mM EDTA, 0.02% NaN3, 2% FCS, 0.1%
saponin, PBS pH 7.4) successively with a-T-ag and a-mouse AF647
antibodies. Cells were analyzed for T-ag signals by FACS. 10,000 cells
were counted, and the percentage of cells with T-ag signal (infected
cells,z20%) was determined and normalized to 100% for the control
situation. In each case, mean values of minimum three independent
experiments ± standard deviation (SD) were shown.
siRNA-Mediated Silencing
siRNA experiments were performed with siRNAs from QIAGEN or
Ambion (Figure S1). Silencing was achieved by double transfection
of 105 HeLa cells with Hiperfect (QIAGEN). 48–72 hr posttransfection
(Figure S1) cells were infected with SV40, or cell lysates were
prepared.
Thiol-Disulfide Modification of SV40
Thiol-disulfide modifications were performed successively for 1 hr (RT)
in the dark by addition of reagents in virion buffer (10 mM HEPES [pH
8.0], 150 mM NaCl, and 1 mM CaCl2). For in vitro disassembly, virus
was incubated with 5 mM dithiothreitol (DTT), 5 mM EGTA, or both.
Alternatively, virus was dialyzed O.N. (4C) against glutathione redox
buffer, or added to cytosolic extracts of HeLa cells (Kutay et al., 1997)
which contained 8 mM reduced glutathione. For sequential alkylation
of reduced and oxidized cysteines, initially 5 mM alkylating reagent
was added, followed by subsequent addition of 10 mM DTT and
20mMalkylating reagent different to the one initially used as indicated.
2% SDS was present during the final alkylation reaction, if indicated.
Immunofluorescence Microscopy
CV-1 cells were seeded on glass coverslips and incubatedwith AF488-
labeled SV40 for 2 hr. At 2 or 8 hr p.i., cells were fixed in 2% formalde-
hyde, permeabilized with 0.05% saponin, and incubated with the ap-
propiate primary and secondary antibodies. Cells were analyzed by
confocal microscopy (Zeiss 510 meta). Signals were obtained within a
linear range of intensities. The amount of signal overlap was quantified
for each confocal slice using Zeiss software. The signal overlap (30%–
70%) was determined for at least ten fields of view per experiment and
all confocal slices thereof. The signal overlap was normalized to 1 for
unperturbed SV40 and compared to SV40 in the presence of 5 mM
DTT, or to AMS-alkylated SV40.
Biochemical Analysis of SV40 during Infection
The proteins of infected cells were alkylated by incubation with either
NEM or MMTS (5 mM) for 15 min at 37C in the dark, lysates were pre-
pared followed by nonreducing SDS-PAGE and immunoblotting.
In Vitro Analysis of ERp57- and PDI-Mediated SV40
Disulfide Modifications
ERp57 and PDI were purified as described (Frickel et al., 2004). SV40,
ERp57, and PDI were dialyzed O.N. (4C) against glutathione redox
buffers (virion buffer including reduced (GSH) and oxidized (GSSG)
glutathione: for cytosolic conditions 8 mM GSH, 80 nM GSSG, for
ER conditions 4 mM GSH, 4 mM GSSG). 50 nM SV40 and indicated
amounts of ERp57 or PDI were mixed and incubated at 37C for 1 hr.528 Cell 131, 516–529, November 2, 2007 ª2007 Elsevier Inc.Samples were alkylated (5 mM IAM), and analyzed by nonreducing
SDS-PAGE and immunoblotting.
Sucrose Gradient Sedimentation
Samples were loaded on 5%–20% linear sucrose gradients
(10 mM HEPES pH 8.0, 50 mM NaCl), and centrifuged for 75 min at
220,000 g (4C). Fractions were TCA-precipitated and analyzed for
VP1 or VP2/3 content by SDS-PAGE and immunoblotting. Signal
intensities were recorded using a Storm scanning device within linear
range and densitrometrically analyzed using ImageJ (NIH). Alterna-
tively, phenol-chloroform extracted fractions were analyzed for dsDNA
content by the Quant-It DNA assay kit (Molecular Probes). In each
case, normalized signal intensities for a representative gradient of
minimum three independent experiments are given.
Electron Microscopy
Virus samples were applied on a carbon-coated 400-mesh for 30 s.
Grids were stained for 30 s with 2% (w/v) uranyl acetate in ddH2O.
Transmission electron microscopy was performed using a FEI
Morgagni 268D electron microscope at 100 kV. Images were analyzed
using Soft Imaging System Software (analySIS).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, four figures, and two Excel tables and can
be found with this article online at http://www.cell.com/cgi/content/
full/131/3/516/DC1/.
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